Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female, 2 months to \< 18 years old.~* Presence of ABSSSI warranting initial hospitalization.~* Presence of ABSSSI with measurable margins of erythema, that includes deeper and/or extensive soft tissue involvement, or requires significant therapeutic surgical intervention~Exclusion Criteria:~* Documented history of any hypersensitivity or allergic reaction to vancomycin, aztreonam, or any β-lactam antimicrobial~* Uncomplicated skin and soft tissue infections~* More than 24 hours of prior antimicrobial therapy ≤ 96 hours before randomization.~* Requirement for any concomitant systemic antimicrobial therapy~* History of seizures, excluding well-documented febrile seizure of childhood.~* Clinical signs or suspicion of meningitis

- Gender: ALL
- Minimum Age: 2 Months
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Ceftaroline fosamil (Type: EXPERIMENTAL): None
- Comparators (Type: ACTIVE_COMPARATOR): Vancomycin +/- Aztreonam Cefazolin +/- Aztreonam

Based on this trial design, predict the completion outcome and termination type (if applicable).